Temozolomide for malignant brain tumours

被引:26
作者
Batchelor, T [1 ]
机构
[1] Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02114 USA
关键词
D O I
10.1016/S0140-6736(00)02055-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1115 / 1116
页数:2
相关论文
共 11 条
[1]   Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma [J].
Bower, M ;
Newlands, ES ;
Bleehen, NM ;
Brada, M ;
Begent, RJH ;
Calvert, H ;
Colquhoun, I ;
Lewis, P ;
Brampton, MH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) :484-488
[2]  
Brock CS, 1998, CANCER RES, V58, P4363
[3]  
*CENTR BRAIN TUM R, 1997, ANN REP
[4]   DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma [J].
Friedman, HS ;
McLendon, RE ;
Kerby, T ;
Dugan, M ;
Bigner, SH ;
Henry, AJ ;
Ashley, DM ;
Krischer, J ;
Lovell, S ;
Rasheed, K ;
Marchev, F ;
Seman, AJ ;
Cokgor, I ;
Rich, J ;
Stewart, E ;
Colvin, OM ;
Provenzale, JM ;
Bigner, DD ;
Haglund, MM ;
Friedman, AH ;
Modrich, PL .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3851-3857
[5]  
HARRAS E, 1996, CANC RATES RISKS
[6]   The Charing Cross Hospital experience with temozolomide in patients with gliomas [J].
Newlands, ES ;
OReilly, SM ;
Glaser, MG ;
Bower, M ;
Evans, H ;
Brock, C ;
Brampton, MH ;
Colquhoun, I ;
Lewis, P ;
RiceEdwards, JM ;
Illingworth, RD ;
Richards, PG .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (13) :2236-2241
[7]   Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials [J].
Newlands, ES ;
Stevens, MFG ;
Wedge, SR ;
Wheelhouse, RT ;
Brock, C .
CANCER TREATMENT REVIEWS, 1997, 23 (01) :35-61
[8]  
Schold SC, 2000, NEURO-ONCOLOGY, V2, P34, DOI 10.1093/neuonc/2.1.34
[9]   O-6-Benzylguanine enhances the sensitivity of a glioma xenograft with low O-6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU [J].
Wedge, SR ;
Newlands, ES .
BRITISH JOURNAL OF CANCER, 1996, 73 (09) :1049-1052
[10]  
YUNG A, 1999, P AN M AM SOC CLIN, V18, pA139